| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.04 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.06 | 0.04 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.091 | 0.05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.091 | 0.05 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.05 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |